| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 03/18/2008 | US7345174 Selectively inducing terminal differentiation of neoplastic cells; antiproliferative agents; antineoplastic agents; antitumor agents; melanomes; acute leukemia, multiple myeloma; carcinomas; neuroblastoma; N-t-butoxycarbonyl- omega -methyl - alpha -aminosuberateanilide |
| 03/18/2008 | US7345091 Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease |
| 03/18/2008 | US7345078 NF-κB inhibitors and uses thereof |
| 03/18/2008 | US7345077 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4- (substituted cycloalkylmethyl) imidazol-2-ones and 4- (substituted cycloalkenylmethyl) imidazol-2-ones and related compounds |
| 03/18/2008 | US7345064 5-(4-pyridyl)valeric acid N-[2-(1-adamantyl)ethyl]-N-pentylamide; Autoimmune diseases such as rheumatoid arthritis, allergy and diabetes |
| 03/13/2008 | WO2008030618A1 Benzo-fused compounds for use in treating metabolic disorders |
| 03/13/2008 | WO2008029825A1 Imidazole derivative |
| 03/13/2008 | WO2008029804A1 Perchloric acid ion trapping agent |
| 03/13/2008 | WO2008028937A1 N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions |
| 03/13/2008 | WO2007107311A3 Organic sulphinic acid derivatives |
| 03/13/2008 | US20080064687 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea |
| 03/13/2008 | US20080064662 Agonists having a biphenyl moiety in combination with an amide linkage at the core of the structure enhances selectivity for S1P1 receptor without causing hypotension or bradycardia; transplant rejection, autoimmune diseases; 2-Amino-N-[4-(biphenyl-4-yloxy)-phenyl]3-hydroxy-2-methyl-propionamide |
| 03/13/2008 | CA2662112A1 Imidazole derivatives and their use as cannabinoid type 2 (cb2) receptor modulators |
| 03/13/2008 | CA2662091A1 N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions |
| 03/12/2008 | EP1896426A2 Process for the synthesis of organic compounds |
| 03/12/2008 | EP1896425A1 Process for the synthesis of 5- (methyl- 1h-imidazol-1-yl) -3- (trifluoromethyl) -benzeneamine |
| 03/12/2008 | EP1618230A4 Imidazoline corrosion inhibitors |
| 03/12/2008 | CN101142192A 1,2-diphenyl-imidazole derivatives and their use as CB1 receptor ligands |
| 03/12/2008 | CN101141957A Compounds and compositions as ppar modulators |
| 03/12/2008 | CN100374516C Printing process using specified azo compounds |
| 03/12/2008 | CN100374448C Diene silicoxyane linking disbenzocyclobutylene monomer and process for preparing prepolymer |
| 03/12/2008 | CN100374424C Heterocyclic amide derivative and use as pesticide |
| 03/11/2008 | US7342118 Imidazole compounds for the treatment of neurodegenerative disorders |
| 03/11/2008 | CA2421880C Resorcinol derivatives |
| 03/11/2008 | CA2237297C Process for the preparation of (1s,4r)-or(1r,4s)-4-(2-amino-6-chloro-9h-purin-9-yl)-2-cyclopentene-1-methanol |
| 03/11/2008 | CA2192764C Integrin receptor antagonists |
| 03/06/2008 | WO2008027466A1 Hydantoin derivatives useful as antibacterial agents |
| 03/06/2008 | WO2008006834A3 Use of imidazole compounds as plasticisers |
| 03/06/2008 | WO2007149842A3 Method of preparing imidazolium surfactants |
| 03/06/2008 | WO2007102999A3 Cb1 antagonists and inverse agonists |
| 03/06/2008 | US20080058532 Method for producing molecular compound |
| 03/06/2008 | US20080058397 Therapeutic substituted hydantoins and related compounds |
| 03/06/2008 | US20080058340 MEK kinase (mitogen-activated ERK-activating kinases or MAP kinase kinase); cancer, tumors, infections, autoimmune disorders, stroke, ischemia, rheumatoid arthritis, multiple sclerosis, psoriasis, restenosis; 1-sulfonamido-2-(phenylamino)-4-fluorobenzene compounds |
| 03/06/2008 | US20080058334 Dermatological or oncological disorders; N-(4-fluorophenyl)-N'-[4-[1-(1H-imidazol-1-yl)-2-methylpropyl]phenyl]urea for example |
| 03/06/2008 | US20080058333 Carbamates such as (1-benzylcyclohexyl)methyl(1S)-5-[(4-morpholinylcarbonyl)amino]-1-(oxo([(1R)-1-phenylethyl]amino)acetyl)pentylcarbamate; osteoporosis |
| 03/06/2008 | US20080058314 Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 03/06/2008 | US20080054223 Light Emitting Complex Salts |
| 03/06/2008 | CA2661605A1 Hydantoin derivatives useful as antibacterial agents |
| 03/05/2008 | EP1893582A2 Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders |
| 03/05/2008 | EP1893196A1 Diarylhydantoin compounds |
| 03/05/2008 | CN101137725A Method and use of acidified modified polymers to bind biocides in paints |
| 03/05/2008 | CN101137616A Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 03/05/2008 | CN101137437A Basic ionic liquids |
| 03/05/2008 | CN101137380A Quinazolinone t-type calcium channel antagonists |
| 03/05/2008 | CN100372852C Synthesis of temozolomide and analogs |
| 03/05/2008 | CN100372532C Imidazolin-2-ylaminophenyl amides as IP antagonists. |
| 03/04/2008 | US7339052 5-benzylmercaptotetrazole in acetonitrile and N-alkyimidazole is used to prepare internucleoside linkages; efficient and rapid |
| 02/28/2008 | WO2008023171A2 Ionic additive for catalysis in biphasic reaction systems |
| 02/28/2008 | WO2008023157A1 Nitrogen containing heterocyclic compounds useful as m3-receptor modulators |
| 02/28/2008 | US20080051608 Preparation of alpha-hydroxy ketones via carbene-catalyzed umpolung reaction of aldehydes |
| 02/28/2008 | US20080051416 Novel Compounds |
| 02/28/2008 | US20080051371 Membrane permeable; ischemia, heart failure, and neurodegenerative disorders |
| 02/28/2008 | CA2697002A1 Ionic additive for catalysis in biphasic reaction systems |
| 02/27/2008 | EP1892245A2 Antineoplastic compounds and pharmaceutical compositions thereof |
| 02/27/2008 | EP1615904B1 Substituted benzosulphonamides as potentiators of glutamate receptors |
| 02/27/2008 | EP1446115B1 Cyanoalkylamino derivatives as protease inhibitors |
| 02/27/2008 | EP1425268B1 Organic sulfates as ionic liquids |
| 02/27/2008 | EP1248612B1 Novel compounds and compositions as protease inhibitors |
| 02/27/2008 | EP1150959B1 Solid-state form of celecoxib having enhanced bioavailability |
| 02/27/2008 | CN101133035A Method for the production of losartan |
| 02/27/2008 | CN101133023A Substituted pyrroles and imidazoles, compositions containing same, manufacturing process therefor and use thereof |
| 02/27/2008 | CN101131897A Aluminum electrolytic capacitor, preparing method for quaternary ammonium salt for super capacitor |
| 02/27/2008 | CN101131887A Ionic liquid containing cupric salt and method for preparing the same |
| 02/27/2008 | CN101130518A Ionic liquid photo generated base alkaline agent, preparing method and uses of the same |
| 02/27/2008 | CN100371318C Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
| 02/26/2008 | US7335779 Acyclic, aromatic, heteroaromatic and cyclic ring containing amido-derivatives, useful as antibacterial agent |
| 02/26/2008 | US7335778 Intermediate for biotin and process for producing the same |
| 02/26/2008 | US7335773 induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; exhibit antiviral and antitumor properties |
| 02/26/2008 | US7335687 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, mycoses, gallstones, hyperproliferative disorders, impaired glucose tolerance, or diabetes; aminocyclohexanol derivatives; e.g. N-(4-(4-[ethyl-(2-hydroxy-ethyl)-amino]-but-1-ynyl)-cyclohexyl)-N-methyl-4-trifluoromethyl-benzenesulfonamide |
| 02/26/2008 | CA2322195C Novel diphenyl-substituted 5-ring-heterocycles, method for producing them and their use as medicaments |
| 02/21/2008 | WO2007144725A3 SYNTHESIS AND EVALUATION OF 18F-LABELLED ALKYL-1-[(R)-1-PHENYLETHYL]-1H-IMIDAZOLE-5-CARBOXYLATE AS A TRACER FOR THE QUANTIFICATION OF β-11-HYDROXYLASE ENZYME IN THE ADRENAL GLANDS |
| 02/21/2008 | WO2007010222A3 Therapeutic agents |
| 02/21/2008 | US20080045723 reacting 1-alkyl (C1-C18)-imidazolium with alkyl (C1-C18) alkane (C1-C18) sulfonates or alkyl (C1-C18) trifluoromethanesulfonates, reacting in a metathesis reaction in aqueous solution alkyl (C1-C18) alkane (C1-C18) sulfonates with alkaline metal salts containing BF4, CF3SO3, (CF3SO2)2N, or (CF3CF2)3PF3 |
| 02/21/2008 | US20080045722 Processes for nitration of n-substituted imidazoles |
| 02/21/2008 | US20080045719 Process for the Preparation of a Metal-Organic Compound Comprising at Least One Imine Ligand |
| 02/21/2008 | US20080045522 Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells |
| 02/21/2008 | US20080045500 Nerve Regeneration Stimulator |
| 02/21/2008 | US20080045470 Ceramides and Apoptosis-Signaling Ligand |
| 02/21/2008 | US20080044380 Hepatitis C Virus Inhibitors |
| 02/21/2008 | US20080044379 (1R)-2-((2S)-2-(5-(6-(4-(2-((2S)-1-((2R)-2-(dimethylamino)-2-phenylacetyl)-2-pyrrolidinyl)-1H-imidazol-5-yl)phenyl)-3-pyridinyl)-1H-imidazol-2-yl)-1-pyrrolidinyl) -N,N-dimethyl-2-oxo-1-phenylethanamine; inhibit the function of the non-structural proteins (NS5A) |
| 02/21/2008 | DE102006038934A1 Herstellung von α-Hydroxyketonen über Carbenkatalysierte Umpolungsreaktion von Aldehyden Production of α-hydroxy ketones via Carbenkatalysierte umpolung of aldehydes |
| 02/20/2008 | EP1889839A1 Bicyclic compound, production and use as HIV inhibitors |
| 02/20/2008 | EP1888533A1 1-(imidazolin-2-yl)amino-1,2-diphenylethane compounds for combating animal pests |
| 02/20/2008 | EP1888517A1 Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor |
| 02/20/2008 | EP1888509A1 Benzoyl-substituted serine amides |
| 02/20/2008 | EP1432417B1 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 02/20/2008 | CN101128455A Heterocyclylamide-substituted imidazoles |
| 02/20/2008 | CN101125831A Method for producing L-histidine |
| 02/20/2008 | CN100369901C Method for preparing 5,5-dimethylhydantion |
| 02/20/2008 | CN100369900C Process for preparing ionic liquid |
| 02/20/2008 | CN100369888C N-alkanoylphenylalanine derivatives |
| 02/19/2008 | US7332608 Potassium channel modulators; cardiovascular disorders; antiarrhythmia agents; synthesis |
| 02/19/2008 | US7332517 1-(1H-indol-3-ylmethyl)-3-(4-nitrophenyl)-5-[2-(4-phenyl-1H-imidazol-2-yl)ethyl]-2thioxo-4imidazolidinone; somastatin receptor affinity; acromegaly, hypophyseal adenomas, endocrine gastroenteropancreatic tumors, as carcinoid syndrome and gastrointestinal bleeding |
| 02/19/2008 | US7332511 Vanilloid receptor ligands and their use in treatments |
| 02/19/2008 | US7332233 Multilayer; charge generating compound, charge transfer compound; blue phosphorescence |
| 02/19/2008 | CA2328927C Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 02/19/2008 | CA2206366C Substituted 2-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 02/14/2008 | WO2008019090A2 Agonists of the sphingosine-1-phosphate receptor |
| 02/14/2008 | WO2008017932A2 Heterocycles useful as inhibitors of carbonic anhydrase |
| 02/14/2008 | WO2008017381A1 Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use |